TITLE

SURVIVORSHIP ANALYSIS AND RADIOGRAPHIC OUTCOME FOLLOWING TANTALUM ROD INSERTION FOR OSTEONECROSIS OF THE FEMORAL HEAD

AUTHOR(S)
Veillette, Christian J. H.; Mehdian, Hossein; Schemitsch, Emil H.; McKee, Michael D.
PUB. DATE
November 2006
SOURCE
Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p48
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: For early stages of osteonecrosis, preservation of the femoral head is the primary objective; however, there has not been a consensus on how best to achieve this goal. Core decompression alone is associated with a lack of structural support with inconsistent outcomes, whereas vascularized fibular grafting requires an extensive surgical procedure with high donor-site morbidity and prolonged rehabilitation. The adjunctive use of a porous tantalum implant offers the advantages of core decompression, structural support, minimally invasive surgery, and no donorsite morbidity. The purpose of this study was to assess the survivorship and to evaluate the clinical results and radiographic outcomes of hips in which osteonecrosis of the femoral head was treated with core decompression and a porous tantalum implant. Methods: We evaluated fifty-four patients (sixty consecutive hips) in whom osteonecrosis of the femoral head was treated with core decompression and insertion of a porous tantalum implant. Fifty-two patients (fifty-eight hips) were available for follow-up at a mean of twenty-four months. All patients were sixty-five years of age or younger (mean age, thirty-five years). According to the classification system of Steinberg et al., one hip (2%) had stage-I disease, forty-nine hips (84%) had stage-II disease, and eight hips (14%) had stage-III disease. Outcome measures that were used included a limb-specific score (Harris hip score), radiographic outcome measures, and survivorship analysis with revision to total hip arthroplasty as the end point. Results: Overall, nine hips (15.5%) were converted to total hip arthroplasty, including six with stage-II disease and three with stage-III disease. The overall survival rates were 91.8% (95% confidence interval, 87.8% to 95.8%) at twelve months, 81.7% (95% confidence interval, 75.8% to 87.6%) at twenty-four months, and 68.1% (95% confidence interval, 54.7% to 81.5%) at forty-eight months. The absence of chronic systemic diseases resulted in a survival rate of 92% at forty-eight months (95% confidence interval, 87.4% to 96.4%). Conclusions: Treatment of early stage osteonecrosis of the femoral head with core decompression and a porous tantalum implant can be accomplished with a minimally invasive technique and no donor-site morbidity. The early clinical results show encouraging survival rates in patients who do not have chronic systemic disease, especially in association with early stage disease. Level of Evidence: Therapeutic Level IV. See Instructions to Authors on jbjs.org for a complete description of levels of evidence.
ACCESSION #
22878559

 

Related Articles

  • POSTERIOR ROTATIONAL OSTEOTOMY FOR NONTRAUMATIC OSTEONECROSIS WITH EXTENSIVE COLLAPSED LESIONS IN YOUNG PATIENTS. Atsumi, Takashi; Kajiwara, Toshihisa; Hiranuma, Yasunari; Tamaoki, Satoshi; Asakura, Yasuhiro // Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p42 

    Background: In young patients with nontraumatic femoral head osteonecrosis with extensive and collapsed lesions, joint preservation is a goal if total joint arthroplasty is to be avoided. We evaluated the effectiveness of a posterior rotational osteotomy in this patient population. Methods: We...

  • BIOPHYSICAL STIMULATION WITH PULSED ELECTROMAGNETIC FIELDS IN OSTEONECROSIS OF THE FEMORAL HEAD. Massari, Leo; Fini, Milena; Cadossi, Ruggero; Setti, Stefania; Traina, Gian Carlo // Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p56 

    Background: Osteonecrosis of the femoral head is the end point of a disease process that results in bone necrosis, joint edema, and cartilage damage. It leads to joint arthritis that necessitates total hip arthroplasty in many patients. Because of its positive effects on osteogenesis and its...

  • BONE IMPACTION GRAFTING FOR CORTICOSTEROID-ASSOCIATED OSTEONECROSIS OF THE KNEE. Rijnen, Wim H. C.; Luttjeboer, Jaap S.; Schreurs, B. Willem; Gardeniers, Jean W. M. // Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p62 

    Background: Osteonecrosis of the distal portion of the femur produces a segment of dead bone in the weight-bearing portion of the femoral condyle, frequently associated with subchondral fracture and collapse and eventually resulting in secondary osteoarthritis. Treatment of these late stages of...

  • Adjacent Segment Pathology Following Anterior Decompression and Fusion Using Cage and Plate for the Treatment of Degenerative Cervical Spinal Diseases. Kyung-Jin Song; Byung-Wan Choi; Jong-Kil Kim // Asian Spine Journal;2014, Vol. 8 Issue 6, p720 

    Study Design: Retrospective study. Purpose: To analyze the incidence and prevalence of clinical adjacent segment pathology (CASP) following anterior decompression and fusion with cage and plate augmentation for degenerative cervical diseases. Overview of Literature: No long-term data on the use...

  • Alendronic acid.  // Reactions Weekly;3/24/2012, Issue 1394, p5 

    The article describes the case of a 58-year-old woman who developed osteonecrosis of the jaw (ONJ) while under alendronic acid treatment regimen for osteoporosis.

  • Risedronic acid.  // Reactions Weekly;6/5/2010, Issue 1304, p31 

    The article describes the cases of two patients who suffered from osteonecrosis and/or osteomyelitis while taking risedronic acid for osteoporosis.

  • Zoledronic acid.  // Reactions Weekly;6/5/2010, Issue 1304, p34 

    The article describes the case of a 61-year-old female patient who suffered from osteonecrosis of the jaw following monthly infusions of zoledronic acid for metastatic breast cancer.

  • Bevacizumab/corticosteroids.  // Reactions Weekly;3/16/2013, Issue 1444, p11 

    The article presents a case study of a patient who developed osteonecrosis while receiving bevacizumab and another patient who received corticosteroids.

  • Alendronic acid/denosumab.  // Reactions Weekly;May2014, Vol. 1502 Issue 1, p5 

    An abstract of the article "Jaw osteonecrosis in a patient with postmenopausal osteoporosis on antiresorptive treatment," by I. Kostoglou-Athanassiou and colleagues is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics